Where they practice, who they consult.
- Beijing Cancer Hospital / Peking University Cancer Hospital (北京大学肿瘤医院), Beijing
- 25+ years in oncologic nuclear medicine and radiopharmacy
- English, Mandarin
What they personally lead.
Training and recognition
Beijing Cancer Hospital's nuclear medicine department is active in PET tracer research and clinical translation, including PSMA and FAPI tracers; the hospital is among China's main clinical trial sites for novel radioligand therapies; Dr. Yang has contributed to Chinese expert consensus on PET imaging in oncology
What to expect
A reasonable option for cancer patients seeking access to novel PET tracers or radioligand therapy clinical trials. Beijing Cancer Hospital's multidisciplinary team review is typically required before novel theranostic therapy.
Check the public record
Look up publications, citations, and academic profile on independent platforms before reaching out.
Results are automated searches and may include other individuals with similar names.
Ask the AI or request a coordinator.
The AI can compare Yang Zhi's background to other specialists in Beijing. A coordinator can confirm appointment availability and English-language support.
Information is provided for reference only and may not reflect current conditions. Verify directly with the hospital before making decisions.